A Phase 2, Multicenter, Randomized, Double blind, Parallel group, Placebo controlled Study Evaluating the Safety and Efficacy of Treatment with Ustekinumab or Golimumab in Subjects with Chronic Sarcoidosis - ND A Phase 2, Multicenter, Randomized, Double blind, Parallel group, Placebo controlled Study Evaluatin ...